Vulvar Cancer

  • Serah Choi
  • Tracy SherertzEmail author


This chapter will discuss the clinical presentation, pathology, staging, management, and radiation techniques for vulvar cancers.


Vulvar cancer Vulvar intraepithelial neoplasia Bartholin’s tumors 



We thank Stephen Shiao MD, PhD, Brian Missett MD, and Joycelyn L. Speight MD, PhD for their work on the prior edition of this chapter.


  1. Beriwal S, Heron DE, Kim H, et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat OncolBiolPhys. 2006;64(5):1395–400.CrossRefGoogle Scholar
  2. Beriwal S, Shukla G, Shinde A, et al. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Radiat Oncol Biol. 2013;85(5):1269–74.CrossRefGoogle Scholar
  3. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57(3):327–34.CrossRefGoogle Scholar
  4. Dusenbery KE, Carlson JW, LaPorte RM, et al. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block. Int J Radiat Oncol Biol Phys. 1994;29:989–98.CrossRefGoogle Scholar
  5. Gaffney DK, King B, Viswanathan AN, et al. Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma. Int J Radiat Oncol Biol Phys. 2016;95(4):1191–200.CrossRefGoogle Scholar
  6. Gill BS, Bernard ME, Lin JF, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol. 2015;137(3):365–72.CrossRefGoogle Scholar
  7. Heaps JM, Fu YS, Montz FJ, et al. Surgical–pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:309–14.CrossRefGoogle Scholar
  8. Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68:733–40.PubMedGoogle Scholar
  9. Kirby TO, Rocconi RP, Numnum TM, et al. Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol. 2005;98:309–12.CrossRefGoogle Scholar
  10. Klopp AH, Eifel PJ, Berek JS, Konstantinopoulous PA. Cancer of the cervix, vagina, and vulva. In: DeVita Jr VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg’s cancer principles & practice of oncology. 10th ed. Philadelphia: Wolters Kluwer Health; 2015. p. 1013–47.Google Scholar
  11. Kunos C, Simpkins F, Gibbons H, et al. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114:537–46.CrossRefGoogle Scholar
  12. Landrum LM, Grainger SL, Skaggs VJ, et al. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol. 2007;106:521–5.CrossRefGoogle Scholar
  13. Landrum LM, Skaggs V, Gould N. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation. Gynecol Oncol. 2008;108(3):584–90.CrossRefGoogle Scholar
  14. Lee LJ, Howitt B, Catalano P, et al. Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. Gynecol Oncol. 2016;142(2):293–8.CrossRefGoogle Scholar
  15. Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30(31):3786–91.CrossRefGoogle Scholar
  16. Montana GS, Kang S. Carcinoma of the vulva. In: Perez CA, Brady LW, Halperin EC, et al., editors. Principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1692–707.Google Scholar
  17. Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulve with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2000;48:1007–13.CrossRefGoogle Scholar
  18. Moore DH, Ali S, Koh W-J, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124(3):529–33.CrossRefGoogle Scholar
  19. Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42:79–85.CrossRefGoogle Scholar
  20. National Cancer Institute.Surveillance, epidemiology, and end results program (SEER). 2016. Accessed 17 Aug 2016.Google Scholar
  21. National Comprehensive Cancer Network.Vulvar cancer (version 1.2016). 2016. Accessed 17 Aug 2016.Google Scholar
  22. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefGoogle Scholar
  23. Petereit DG, Mehta MP, Buchler DA, et al. Inguinofemoral radiation of N0, N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys. 1993;27(4):963–7.CrossRefGoogle Scholar
  24. Russell AH, Horowitz NS. Vulvar and vaginal carcinoma. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 4th ed. Philadelphia: Churchill Livingstone; 2015. p. 1230–63.Google Scholar
  25. Stehman FB, Bundy BN, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 1992;24:389–96.CrossRefGoogle Scholar
  26. Van der Zee AG, Oonk MH, DeHullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations